Area of research
Oncology · Cancer Research
Research interest
Research focused on microRNA and Cancer research, with related work in Cell cycle, Breast cancer, Circulating tumor cell. Notable publications include 'Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset', 'The Network of Non-coding RNAs in Cancer Drug Resistance', and 'SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?'.
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA
The Network of Non-coding RNAs in Cancer Drug Resistance
SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
Loss of miR-204 expression is a key event in melanoma
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants
Abstract 3856: Identification of circulating tumour cells in breast cancer patient-derived xenograft models
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study